rubella
RUBELLA
Rubella, also known as German measles or 3-day measles, is a mild often exanthematous disease of infants and children that is severe and associated with complications in adults. It is self-limiting disease associated with a characteristic maculopapular rash.
It is caused by a single-stranded RNA virus classified as a togavirus, genus Rubivirus.
Transmission is through airborne or droplets shed from respiratory secretions.
Highly communicable at the onset of the rash, however viral shedding may also occur 5-7 days before, to 5-7 days or more following appearance of the rash.
The incubation period is 14-21 days.

Introduction

  • Rubella, also known as German measles or 3-day measles, is a mild & self-limiting disease associated w/ a characteristic rash
  • Before vaccination era, the peak incidence is in 5-14 yrs of age
    • Currently, it involves the adolescents or young adults

 Congenital Rubella Syndrome (CRS)

  • Neonatal manifestations of rubella during maternal infection
  •  Severity of effects on the fetus varies according to the gestational age at which the maternal infection occurs
    • The most severe & widespread defects occur during maternal infection in the 1st trimester of gestation

Etiology

  • A single-stranded RNA virus classified as a togavirus, genus Rubivirus
  • Transmission is through airborne or droplets shed from respiratory secretions
  • Highly communicable on the onset of the rash, however viral shedding may also occur 5-7 days before, to 5-7 days or more following appearance of the rash
  • Incubation period is 14-21 days

Signs and Symptoms

  • Prodromal symptoms of low-grade fever, conjunctivitis, sore throat, coryza, headaches, malaise & lymphadenopathy usually last for 1-5 days before the onset of rash
    • The prominent lymph nodes are the suboccipital, postauricular & anterior cervical nodes
  • Rash is maculopapular & appears 14-17 days after exposure
    • Rash begins on the face & forehead as small, irregular pink macules that coalesce
    • It spreads centrifugally to the trunk & extremities as discrete macules
    • It then resolves w/in 3 days in the same order it appeared, usually without desquamation
    • May be more prominent after taking a bath or a hot shower
    • The rash may be pruritic
  • Forschheimer spots on the soft palate may be noted about the time of rash onset, but are not diagnostic
  • May be asymptomatic in 25% to 50% of patients
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 13 Oct 2016
Children born to obese mothers are at increased risk of developing autism spectrum disorder (ASD) compared with children born to normal-weight mothers, according to data from a review and meta-analysis.
Yap Te-Lu, Anette Sundfor Jacobsen, 01 Oct 2013

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies

Yap Te-Lu, Anette Sundfor Jacobsen, 01 Dec 2012

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies.

Yap Te-Lu, Anette Sundfor Jacobsen, 01 Apr 2011

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies.